This study identified 2 diagnostic panels based on microRNA expression in whole blood with the potential to distinguish patients with pancreatic cancer from healthy controls. Further research is necessary to understand whether these have clinical implications for early detection of pancreatic cancer and how much this information adds to serum CA19-9.
No takes yet. Share an insight, caveat, or question.
Schultz et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: